Buys
Open market- Shares
- +1,336
- Avg price
- $81.63
- Total value
- +$109,058
David Weill - Director at TransMedics Group, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TMDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for David Weill in TransMedics Group, Inc.
Sells
Open market- Shares
- -8,571
- Avg price
- $142.05
- Total value
- -$1,217,494
Net
Past year- Shares
- -7,235
- Share %
- -73%
- Total value
- -$1,108,437
Reported holdings for David Weill in TransMedics Group, Inc.
Form 4 holding
Director
TransMedics Group, Inc.
- Security class
- Common Stock
- Shares / value
- 16,392
- Estimated value
- $1,338,078
- Report date
- 11 Sep 2026
- Price
- $81.63
- Ownership
- Direct
Form 4 holding
Director
TransMedics Group, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 1,429
- Estimated value
- Report date
- 04 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for David Weill in TransMedics Group, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.